Neograft Technologies Inc:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Neograft Technologies Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C10338
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Neograft Technologies Inc (Neograft) is a medical device company that cardiac technologies for use in heart bypass procedures. The company offers solutions such as saphenous vein harvesting, coronary artery bypass graft, and others. It develops and provides angioshield, which is a transformative technology that creates a structural polymeric support layer providing strength against over dilation from arterial pressure. The company offers angioshield which is an intraperative system that creates a micro-fibrous surrounding the outside surface of a harvested vein to mechanically reinforce and protect it from overdilation. Neograft is headquartered in Taunton, Massachusetts, the US.

Neograft Technologies Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Neograft Technologies Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Neograft Technologies Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Neograft Technologies Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Neograft Technologies Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Neograft Technologies Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Neograft Technologies Inc, Medical Equipment, Deal Details 10
Venture Financing 10
Neograft Technologies Raises USD5 Million in Venture Financing 10
Neograft Technologies Raises USD11 Million in Venture Financing 11
Neograft Technologies Raises US$4 Million In Venture Financing 12
AorTech International Enters into Licensing Agreement with Neograft 13
Neograft Technologies Inc – Key Competitors 14
Neograft Technologies Inc – Key Employees 15
Neograft Technologies Inc – Locations And Subsidiaries 16
Head Office 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Neograft Technologies Inc, Medical Equipment, Key Facts 2
Neograft Technologies Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Neograft Technologies Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Neograft Technologies Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Neograft Technologies Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Neograft Technologies Inc, Deals By Market, 2012 to YTD 2018 8
Neograft Technologies Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Neograft Technologies Raises USD5 Million in Venture Financing 10
Neograft Technologies Raises USD11 Million in Venture Financing 11
Neograft Technologies Raises US$4 Million In Venture Financing 12
AorTech International Enters into Licensing Agreement with Neograft 13
Neograft Technologies Inc, Key Competitors 14
Neograft Technologies Inc, Key Employees 15

List of Figures
Neograft Technologies Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Neograft Technologies Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Neograft Technologies Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Neograft Technologies Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Neograft Technologies Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Neograft Technologies Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Neograft Technologies Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Neograft Technologies Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Neograft Technologies Inc:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Resverlogix Corp (RVX)-製薬・医療分野:企業M&A・提携分析
    Summary Resverlogix Corp (Resverlogix) is an epigenetics company that develops small molecule therapeutics for Bromodomain and ExtraTerminal Domain (BET) inhibition. The company provides lead product such as RVX-208 (apabetalone), is a BET inhibitor under phase III clinical trial. Its RVX-208 is bei …
  • Dow Jones & Co Inc:企業の戦略的SWOT分析
    Dow Jones & Co Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Tulip Diagnostics (P) Ltd-医療機器分野:企業M&A・提携分析
    Summary Tulip Diagnostics (P) Ltd (Tulip Diagnostics), a subsidiary of Tulip Group is a diagnostic company that manufactures and markets in vitro diagnostic reagents and kits for the medical markets. The company provides assay systems for immunohaematology, hematology, rheumatology, infectious disea …
  • OncoTherapy Science Inc (4564):製薬・医療:M&Aディール及び事業提携情報
    Summary OncoTherapy Science Inc (OncoTherapy) is a biotechnology company that discovers and develops antibody drugs for treating cancer. The company offers products under antibodies, cancer vaccines and small molecule drugs. It provides contract research services. OncoTherapy conducts research and d …
  • Clayton Homes Inc:企業の戦略・SWOT・財務情報
    Clayton Homes Inc - Strategy, SWOT and Corporate Finance Report Summary Clayton Homes Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Uelzena eG:企業の戦略・SWOT・財務情報
    Uelzena eG - Strategy, SWOT and Corporate Finance Report Summary Uelzena eG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Evoqua Water Technologies Corp (AQUA):企業の財務・戦略的SWOT分析
    Evoqua Water Technologies Corp (AQUA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • University of Pennsylvania-医療機器分野:企業M&A・提携分析
    Summary University of Pennsylvania (UOP) is an educational university that provides distance learning facilities for professional courses. The university offers courses such as art and archaeology, accounting, biochemistry, bioengineering, biomedical graduate studies, city and regional planning, cri …
  • Basin Electric Power Cooperative
    Basin Electric Power Cooperative - Strategy, SWOT and Corporate Finance Report Summary Basin Electric Power Cooperative - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Pluristem Therapeutics Inc (PSTI):企業の財務・戦略的SWOT分析
    Summary Pluristem Therapeutics Inc (Pluristem) operates as a clinical-stage biotherapy company that focuses on the development of placental-derived cell therapies. Its PLacental eXpanded (PLX) cells are adherent stromal cells that can be administered to patients without tissue or genetic matching. T …
  • Hengyuan Refining Company Bhd (HENGYUAN):企業の財務・戦略的SWOT分析
    Hengyuan Refining Company Bhd (HENGYUAN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Lululemon Athletica, Inc. (LULU):企業の財務・戦略的SWOT分析
    Lululemon Athletica, Inc. (LULU) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Alfresa Holdings Corp (2784):製薬・医療:M&Aディール及び事業提携情報
    Summary Alfresa Holdings Corp (Alfresa) is a manufacturer and marketer of pharmaceuticals, diagnostic reagent and medical devices. The company offers ethical pharmaceuticals wholesaling, self-medication products and manufacturing. It’s ethical pharmaceutical wholesaling business supplies diagnostic …
  • Sutro Biopharma Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Sutro Biopharma Inc (Sutro Biopharma), formerly Fundamental Applied Biology Inc, discovers, develops and manufactures novel cancer medicines which include antibody-drug conjugates (ADC’s), bispecific antibodies, and antibody-based therapeutics targeting immuno-oncology pathways. Its pipeline …
  • Alligator Bioscience AB (ATORX):製薬・医療:M&Aディール及び事業提携情報
    Summary Alligator Bioscience AB (Alligator Bioscience) is a clinical-stage biotechnology company that discovers and develops antibody based pharmaceuticals for the treatment of cancer. The company’s pipeline products include ADC-1013, ATOR-1015, ATOR-1017 and ALG.APV-527. The ADC-1013, currently und …
  • MDC Holdings Inc:企業の戦略・SWOT・財務情報
    MDC Holdings Inc - Strategy, SWOT and Corporate Finance Report Summary MDC Holdings Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • KitCheck Inc:医療機器:M&Aディール及び事業提携情報
    Summary KitCheck Inc (KitCheck) is a provider of automated hospital pharmacy kit processing and medication tracking software solution. The company’s Kit Check is an automated medication tray management system based on scalable cloud software platform uses RFID tags to track each medication that help …
  • Tourism Holdings Limited
    Tourism Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Tourism Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Standard Life plc:企業のM&A・事業提携・投資動向
    Standard Life plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Standard Life plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), div …
  • Tokyu Land Corporation:企業の戦略・SWOT・財務情報
    Tokyu Land Corporation - Strategy, SWOT and Corporate Finance Report Summary Tokyu Land Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆